TEPKINLY® is the first and only subcutaneous bispecific antibody approved as a monotherapy for adult patients with relapsed or refractory diffuse large B-cell lymphoma after two or more lines of.
The interaction between the respiratory viruses SARS-CoV-2, influenza, and RSV, poses ongoing challenges. Personal protective measures, testing, and vaccination are critical components of our strategy to mitigate the impact of these viruses.
UCB announces approval of RYSTIGGO[®] and ZILBRYSQ[®] for the treatment of adult patients with generalized myasthenia gravis in Japan Japanese Ministry.
Safety planning by peers is feasible and acceptable to patients, might result in decreased ED visits, and may represent a way of implementing safety plans in rural EDs.
There is an urgent need to implement proactive measures so the future population can enjoy a healthy, safe, and sustainable existence. There is a need to establish sustainable processes before the population reaches numbers that exceed what current infrastructure can maintain.